Mechanisms of glioma-associated neovascularization

American Journal of Pathology

Volumn 181, Issue 4, 2012, Pages 1126-1141

  Hardee, Matthew E ^a   Zagzag, David ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ESTROGEN RELATED RECEPTOR ALPHA; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; BLOOD BRAIN BARRIER; CANCER CONTROL; CELL TRANSDIFFERENTIATION; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HYPOXIA; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THERAPY RESISTANCE; TUMOR RECURRENCE; TUMOR VASCULARIZATION; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BRAIN NEOPLASMS; CELL HYPOXIA; GLIOMA; HUMANS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84866510711     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.06.030     Document Type: Review

References (100)

1. S. Brem, R. Cotran, J. Folkman Tumor angiogenesis: a quantitative method for histologic grading J Natl Cancer Inst 48 1972 347 356
2. J.M. Heddleston, Z. Li, J.D. Lathia, S. Bao, A.B. Hjelmeland, J.N. Rich Hypoxia inducible factors in cancer stem cells Br J Cancer 102 2010 789 795
3. G.L. Semenza Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Oncogene 29 2010 625 634
4. J.M. Heddleston, Z. Li, R.E. McLendon, A.B. Hjelmeland, J.N. Rich The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype Cell Cycle 8 2009 3274 3284
5. J. Holash, P.C. Maisonpierre, D. Compton, P. Boland, C.R. Alexander, D. Zagzag, G.D. Yancopoulos, S.J. Wiegand Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF Science 284 1999 1994 1998 (Pubitemid 29309448)
6. D. Zagzag, R. Amirnovin, M.A. Greco, H. Yee, J. Holash, S.J. Wiegand, S. Zabski, G.D. Yancopoulos, M. Grumet Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis Lab Invest 80 2000 837 849 (Pubitemid 30421801)
7. Y. Reiss, M.R. Machein, K.H. Plate The role of angiopoietins during angiogenesis in gliomas Brain Pathol 15 2005 311 317 (Pubitemid 41677430)
8. Y. Rong, D.L. Durden, E.G. Van Meir, D.J. Brat 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis J Neuropathol Exp Neurol 65 2006 529 539 (Pubitemid 44288937)
9. F. Winkler, Y. Kienast, M. Fuhrmann, L. Von Baumgarten, S. Burgold, G. Mitteregger, H. Kretzschmar, J. Herms Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis Glia 57 2009 1306 1315
10. M.P. Simon, R. Tournaire, J. Pouyssegur The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1 J Cell Physiol 217 2008 809 818
11. B. Das, H. Yeger, R. Tsuchida, R. Torkin, M.F. Gee, P.S. Thorner, M. Shibuya, D. Malkin, S. Baruchel A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma Cancer Res 65 2005 7267 7275 (Pubitemid 41161258)
12. V. Montana, H. Sontheimer Bradykinin promotes the chemotactic invasion of primary brain tumors J Neurosci 31 2011 4858 4867
13. S. Brem The role of vascular proliferation in the growth of brain tumors Clin Neurosurg 23 1976 440 453
14. G. Zadeh, K. Koushan, L. Pillo, P. Shannon, A. Guha Role of Ang1 and its interaction with VEGF-A in astrocytomas J Neuropathol Exp Neurol 63 2004 978 989 (Pubitemid 39202500)
15. M. Hellström, L.K. Phng, J.J. Hofmann, E. Wallgard, L. Coultas, P. Lindblom, J. Alva, A.K. Nilsson, L. Karlsson, N. Gaiano, K. Yoon, J. Rossant, M.L. Iruela-Arispe, M. Kalén, H. Gerhardt, C. Betsholtz Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis Nature 445 2007 776 780 (Pubitemid 46279716)
16. S. Sawamiphak, S. Seidel, C.L. Essmann, G.A. Wilkinson, M.E. Pitulescu, T. Acker, A. Acker-Palmer Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis Nature 465 2010 487 491
17. D. Wang, J.C. Anderson, C.L. Gladson The role of the extracellular matrix in angiogenesis in malignant glioma tumors Brain Pathol 15 2005 318 326 (Pubitemid 41677431)
18. P. Lindahl, B.R. Johansson, P. Levéen, C. Betsholtz Pericyte loss and microaneurysm formation in PDGF-B-deficient mice Science 277 1997 242 245 (Pubitemid 27446080)
19. R. Kalluri Basement membranes: structure, assembly and role in tumour angiogenesis Nat Rev Cancer 3 2003 422 433 (Pubitemid 37328846)
20. J. Ridgway, G. Zhang, Y. Wu, S. Stawicki, W.C. Liang, Y. Chanthery, J. Kowalski, R.J. Watts, C. Callahan, I. Kasman, M. Singh, M. Chien, C. Tan, J.A. Hongo, F. de Sauvage, G. Plowman, M. Yan Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis Nature 444 2006 1083 1087 (Pubitemid 46018529)
21. I. Noguera-Troise, C. Daly, N.J. Papadopoulos, S. Coetzee, P. Boland, N.W. Gale, H.C. Lin, G.D. Yancopoulos, G. Thurston Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis Nature 444 2006 1032 1037 (Pubitemid 46018516)
22. J.A. Nagy, A.M. Dvorak, H.F. Dvorak VEGF-A and the induction of pathological angiogenesis Annu Rev Pathol 2 2007 251 275 (Pubitemid 46448066)
23. D. Zagzag, H. Zhong, J.M. Scalzitti, E. Laughner, J.W. Simons, G.L. Semenza Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression Cancer 88 2000 2606 2618 (Pubitemid 30331970)
24. I. Fischer, J.P. Gagner, M. Law, E.W. Newcomb, D. Zagzag Angiogenesis in gliomas: biology and molecular pathophysiology Brain Pathol 15 2005 297 310 (Pubitemid 41677429)
25. K. Lamszus, U. Ulbricht, J. Matschke, M.A. Brockmann, R. Fillbrandt, M. Westphal Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A Clin Cancer Res 9 2003 1399 1405 (Pubitemid 36418393)
26. K.H. Plate, G. Breier, H.A. Weich, W. Risau Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo Nature 359 1992 845 848
27. D. Zagzag, Y. Lukyanov, L. Lan, M.A. Ali, M. Esencay, O. Mendez, H. Yee, E.B. Voura, E.W. Newcomb Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion Lab Invest 86 2006 1221 1232 (Pubitemid 44789912)
28. R.M. Strieter, J.A. Belperio, R.J. Phillips, M.P. Keane CXC chemokines in angiogenesis of cancer Semin Cancer Biol 14 2004 195 200 (Pubitemid 38586745)
29. A. Salmaggi, M. Gelati, B. Pollo, S. Frigerio, M. Eoli, A. Silvani, G. Broggi, E. Ciusani, D. Croci, A. Boiardi, M. De Rossi CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells J Neurooncol 67 2004 305 317 (Pubitemid 39137361)
30. S.X. Yang, J.H. Chen, X.F. Jiang, Q.L. Wang, Z.Q. Chen, W. Zhao, Y.H. Feng, R. Xin, J.Q. Shi, X.W. Bian Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor Biochem Biophys Res Commun 335 2005 523 528 (Pubitemid 41140253)
31. A.M. Jubb, T.Q. Pham, A.M. Hanby, G.D. Frantz, F.V. Peale, T.D. Wu, H.W. Koeppen, K.J. Hillan Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours J Clin Pathol 57 2004 504 512 (Pubitemid 38621796)
32. Z. Arany, S.Y. Foo, Y. Ma, J.L. Ruas, A. Bommi-Reddy, G. Girnun, M. Cooper, D. Laznik, J. Chinsomboon, S.M. Rangwala, K.H. Baek, A. Rosenzweig, B.M. Spiegelman HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha Nature 451 2008 1008 1012 (Pubitemid 351301733)
33. M.B. Parliament, M.J. Allalunis-Turner, A.J. Franko, P.L. Olive, R. Mandyam, C. Santos, B. Wolokoff Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours Br J Cancer 82 2000 635 641 (Pubitemid 30085202)
34. B. Kaur, C. Tan, D.J. Brat, D.E. Post, E.G. Van Meir Genetic and hypoxic regulation of angiogenesis in gliomas J Neurooncol 70 2004 229 243 (Pubitemid 39545734)
35. H. Ohgaki, P. Dessen, B. Jourde, S. Horstmann, T. Nishikawa, P.L. Di Patre, C. Burkhard, D. Schuler, N.M. Probst-Hensch, P.C. Maiorka, N. Baeza, P. Pisani, Y. Yonekawa, M.G. Yasargil, U.M. Lütolf, P. Kleihues Genetic pathways to glioblastoma: a population-based study Cancer Res 64 2004 6892 6899 (Pubitemid 39330996)
36. C. Folkins, Y. Shaked, S. Man, T. Tang, C.R. Lee, Z. Zhu, R.M. Hoffman, R.S. Kerbel Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1 [Erratum appeared in Cancer Res 2009, 69:8216] Cancer Res 69 2009 7243 7251
37. S. Bao, Q. Wu, S. Sathornsumetee, Y. Hao, Z. Li, A.B. Hjelmeland, Q. Shi, R.E. McLendon, D.D. Bigner, J.N. Rich Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor Cancer Res 66 2006 7843 7848 (Pubitemid 44299144)
38. D. Lyden, K. Hattori, S. Dias, C. Costa, P. Blaikie, L. Butros, A. Chadburn, B. Heissig, W. Marks, L. Witte, Y. Wu, D. Hicklin, Z. Zhu, N.R. Hackett, R.G. Crystal, M.A. Moore, K.A. Hajjar, K. Manova, R. Benezra, S. Rafii Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nat Med 7 2001 1194 1201 (Pubitemid 33063774)
39. M.R. Machein, S. Renninger, E. de Lima-Hahn, K.H. Plate Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas Brain Pathol 13 2003 582 597 (Pubitemid 37420701)
40. M.B. Ruzinova, R.A. Schoer, W. Gerald, J.E. Egan, P.P. Pandolfi, S. Rafii, K. Manova, V. Mittal, R. Benezra Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors Cancer Cell 4 2003 277 289 (Pubitemid 37329792)
41. H. Spring, T. Schüler, B. Arnold, G.J. Hämmerling, R. Ganss Chemokines direct endothelial progenitors into tumor neovessels Proc Natl Acad Sci USA 102 2005 18111 18116 (Pubitemid 41798510)
42. S. Rafii, D. Lyden Cancer A few to flip the angiogenic switch Science 319 2008 163 164
43. S. Furuhata, K. Ando, M. Oki, K. Aoki, S. Ohnishi, K. Aoyagi, H. Sasaki, H. Sakamoto, T. Yoshida, S. Ohnami Gene expression profiles of endothelial progenitor cells by oligonucleotide microarray analysis Mol Cell Biochem 298 2007 125 138 (Pubitemid 46605290)
44. C.E. Lewis, M. De Palma, L. Naldini Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2 Cancer Res 67 2007 8429 8432 (Pubitemid 47437413)
45. M.A. Venneri, M. De Palma, M. Ponzoni, F. Pucci, C. Scielzo, E. Zonari, R. Mazzieri, C. Doglioni, L. Naldini Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer Blood 109 2007 5276 5285 (Pubitemid 46890548)
46. C. Murdoch, M. Muthana, S.B. Coffelt, C.E. Lewis The role of myeloid cells in the promotion of tumour angiogenesis Nat Rev Cancer 8 2008 618 631
47. M. De Palma, C. Murdoch, M.A. Venneri, L. Naldini, C.E. Lewis Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications Trends Immunol 28 2007 519 524
48. B. Li, E.E. Sharpe, A.B. Maupin, A.A. Teleron, A.L. Pyle, P. Carmeliet, P.P. Young VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization FASEB J 20 2006 1495 1497
49. G. Tabatabai, B. Frank, R. Möhle, M. Weller, W. Wick Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12 Brain 129 2006 2426 2435 (Pubitemid 44522127)
50. R. Du, K.V. Lu, C. Petritsch, P. Liu, R. Ganss, E. Passegué, H. Song, S. Vandenberg, R.S. Johnson, Z. Werb, G. Bergers HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion Cancer Cell 13 2008 206 220 (Pubitemid 351318372)
51. J.B. Rubin, A.L. Kung, R.S. Klein, J.A. Chan, Y. Sun, K. Schmidt, M.W. Kieran, A.D. Luster, R.A. Segal A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors Proc Natl Acad Sci USA 100 2003 13513 13518 (Pubitemid 37444773)
52. D. Zagzag, M. Esencay, O. Mendez, H. Yee, I. Smirnova, Y. Huang, L. Chiriboga, E. Lukyanov, M. Liu, E.W. Newcomb Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures Am J Pathol 173 2008 545 560
53. M. Aghi, K.S. Cohen, R.J. Klein, D.T. Scadden, E.A. Chiocca Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes Cancer Res 66 2006 9054 9064 (Pubitemid 44521124)
54. D.M. Smadja, I. Bièche, G. Uzan, H. Bompais, L. Muller, C. Boisson-Vidal, M. Vidaud, M. Aiach, P. Gaussem PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system Arterioscler Thromb Vasc Biol 25 2005 2321 2327 (Pubitemid 41552649)
55. J.P. Shaw, R. Basch, P. Shamamian Hematopoietic stem cells and endothelial cell precursors express Tie-2, CD31 and CD45 Blood Cells Mol Dis 32 2004 168 175 (Pubitemid 38147714)
56. V. Udani, J. Santarelli, Y. Yung, S. Cheshier, A. Andrews, Z. Kasad, V. Tse Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors Neurol Res 27 2005 801 806 (Pubitemid 41790264)
57. C. Murdoch, S. Tazzyman, S. Webster, C.E. Lewis Expression of Tie-2 by human monocytes and their responses to angiopoietin-2 J Immunol 178 2007 7405 7411 (Pubitemid 46847468)
58. M. Kioi, H. Vogel, G. Schultz, R.M. Hoffman, G.R. Harsh, J.M. Brown Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice J Clin Invest 120 2010 694 705
59. Z.N. Demou, M.J. Hendrix Microgenomics profile the endogenous angiogenic phenotype in subpopulations of aggressive melanoma J Cell Biochem 105 2008 562 573
60. W.Y. Yue, Z.P. Chen Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem 53 2005 997 1002
61. C.A. Shaifer, J. Huang, P.C. Lin Glioblastoma cells incorporate into tumor vasculature and contribute to vascular radioresistance Int J Cancer 127 2010 2063 2075
62. X.M. Liu, Q.P. Zhang, Y.G. Mu, X.H. Zhang, K. Sai, J.C. Pang, H.K. Ng, Z.P. Chen Clinical significance of vasculogenic mimicry in human gliomas J Neurooncol 105 2011 173 179
63. B. Sun, D. Zhang, S. Zhang, W. Zhang, H. Guo, X. Zhao Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma Cancer Lett 249 2007 188 197 (Pubitemid 46452927)
64. J. Dong, Q. Zhang, Q. Huang, H. Chen, Y. Shen, X. Fei, T. Zhang, Y. Diao, Z. Wu, Z. Qin, Q. Lan, X. Gu Glioma stem cells involved in tumor tissue remodeling in a xenograft model J Neurosurg 113 2010 249 260
65. Y. Chen, Z. Jing, C. Luo, M. Zhuang, J. Xia, Z. Chen, Y. Wang Vasculogenic mimicry-potential target for glioblastoma therapy: an in vitro and in vivo study Med Oncol 29 2012 324 331
66. S. El Hallani, B. Boisselier, F. Peglion, A. Rousseau, C. Colin, A. Idbaih, Y. Marie, K. Mokhtari, J.L. Thomas, A. Eichmann, J.Y. Delattre, A.J. Maniotis, M. Sanson A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry Brain 133 2010 973 982
67. Y. Soda, T. Marumoto, D. Friedmann-Morvinski, M. Soda, F. Liu, H. Michiue, S. Pastorino, M. Yang, R.M. Hoffman, S. Kesari, I.M. Verma From the Cover: Feature Article: Transdifferentiation of glioblastoma cells into vascular endothelial cells Proc Natl Acad Sci USA 108 2011 4274 4280
68. Q. Shen, S.K. Goderie, L. Jin, N. Karanth, Y. Sun, N. Abramova, P. Vincent, K. Pumiglia, S. Temple Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells Science 304 2004 1338 1340 (Pubitemid 38697433)
69. L. Ricci-Vitiani, R. Pallini, M. Biffoni, M. Todaro, G. Invernici, T. Cenci, G. Maira, E.A. Parati, G. Stassi, L.M. Larocca, R. De Maria Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells [Erratum appeared in Nature 2011, 477:238 and in Nature 2011, 469:432] Nature 468 2010 824 828
70. R. Wang, K. Chadalavada, J. Wilshire, U. Kowalik, K.E. Hovinga, A. Geber, B. Fligelman, M. Leversha, C. Brennan, V. Tabar Glioblastoma stem-like cells give rise to tumour endothelium Nature 468 2010 829 833
71. E. Balza, P. Castellani, A. Zijlstra, D. Neri, L. Zardi, A. Siri Lack of specificity of endoglin expression for tumor blood vessels Int J Cancer 94 2001 579 585
72. Y. Zhao, J. Dong, Q. Huang, M. Lou, A. Wang, Q. Lan Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro Brain Res Bull 82 2010 308 312
73. J. Dong, Y. Zhao, Q. Huang, X. Fei, Y. Diao, Y. Shen, H. Xiao, T. Zhang, Q. Lan, X. Gu Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation Stem Cell Rev 7 2011 141 152
74. S.C. Williams, M.A. Karajannis, L. Chiriboga, J.G. Golfinos, A. von Deimling, D. Zagzag R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1alpha upregulation in adult glioma Acta Neuropathol 121 2011 279 281
75. C. Calabrese, H. Poppleton, M. Kocak, T.L. Hogg, C. Fuller, B. Hamner, E.Y. Oh, M.W. Gaber, D. Finklestein, M. Allen, A. Frank, I.T. Bayazitov, S.S. Zakharenko, A. Gajjar, A. Davidoff, R.J. Gilbertson A perivascular niche for brain tumor stem cells Cancer Cell 11 2007 69 82 (Pubitemid 46054518)
76. A.D. Norden, J. Drappatz, P.Y. Wen Antiangiogenic therapies for high-grade glioma Nat Rev Neurol 5 2009 610 620
77. C. Gomez-Manzano, J. Holash, J. Fueyo, J. Xu, C.A. Conrad, K.D. Aldape, J.F. de Groot, B.N. Bekele, W.K. Yung VEGF Trap induces antiglioma effect at different stages of disease Neuro Oncol 10 2008 940 945
78. P. Kunkel, U. Ulbricht, P. Bohlen, M.A. Brockmann, R. Fillbrandt, D. Stavrou, M. Westphal, K. Lamszus Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2 Cancer Res 61 2001 6624 6628 (Pubitemid 32896475)
79. A.D. Norden, G.S. Young, K. Setayesh, A. Muzikansky, R. Klufas, G.L. Ross, A.S. Ciampa, L.G. Ebbeling, B. Levy, J. Drappatz, S. Kesari, P.Y. Wen Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence Neurology 70 2008 779 787
80. A. Narayana, P. Kelly, J. Golfinos, E. Parker, G. Johnson, E. Knopp, D. Zagzag, I. Fischer, S. Raza, P. Medabalmi, P. Eagan, M.L. Gruber Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival J Neurosurg 110 2009 173 180
81. K. Beal, L.E. Abrey, P.H. Gutin Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches Radiat Oncol 6 2011 2 15
82. I. Fischer, C.H. Cunliffe, R.J. Bollo, S. Raza, D. Monoky, L. Chiriboga, E.C. Parker, J.G. Golfinos, P.J. Kelly, E.A. Knopp, M.L. Gruber, D. Zagzag, A. Narayana High-grade glioma before and after treatment with radiation and Avastin: initial observations Neuro Oncol 10 2008 700 708
83. J.M. Ebos, R.S. Kerbel Antiangiogenic therapy: impact on invasion, disease progression, and metastasis [Erratum appeared in Nat Rev Clin Oncol 2011, 8:316 and in Nat Rev Clin Oncol 2011, 8:221] Nat Rev Clin Oncol 8 2011 210 221
84. J.M. Ebos, C.R. Lee, W. Cruz-Munoz, G.A. Bjarnason, J.G. Christensen, R.S. Kerbel Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis Cancer Cell 15 2009 232 239
85. J.L. Rubenstein, J. Kim, T. Ozawa, M. Zhang, M. Westphal, D.F. Deen, M.A. Shuman Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption Neoplasia 2 2000 306 314
86. G. Auf, A. Jabouille, S. Guérit, R. Pineau, M. Delugin, M. Bouchecareilh, N. Magnin, A. Favereaux, M. Maitre, T. Gaiser, A. von Deimling, M. Czabanka, P. Vajkoczy, E. Chevet, A. Bikfalvi, M. Moenner Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma Proc Natl Acad Sci USA 107 2010 15553 15558
87. P.O. Sakariassen, L. Prestegarden, J. Wang, K.O. Skaftnesmo, R. Mahesparan, C. Molthoff, P. Sminia, E. Sundlisaeter, A. Misra, B.B. Tysnes, M. Chekenya, H. Peters, G. Lende, K.H. Kalland, A.M. Oyan, K. Petersen, I. Jonassen, A. van der Kogel, B.G. Feuerstein, A.J. Terzis, R. Bjerkvig, P.O. Enger Angiogenesis-independent tumor growth mediated by stem-like cancer cells Proc Natl Acad Sci USA 103 2006 16466 16471 (Pubitemid 44715219)
88. R.M. Zuniga, R. Torcuator, R. Jain, J. Anderson, T. Doyle, S. Ellika, L. Schultz, T. Mikkelsen Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan J Neurooncol 91 2009 329 336
89. A.K. Lucio-Eterovic, Y. Piao, J.F. de Groot Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy Clin Cancer Res 15 2009 4589 4599
90. M. Pàez-Ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Viñals, M. Inoue, G. Bergers, D. Hanahan, O. Casanovas Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell 15 2009 220 231
91. M.H. Barcellos-Hoff, E.W. Newcomb, D. Zagzag, A. Narayana Therapeutic targets in malignant glioblastoma microenvironment Semin Radiat Oncol 19 2009 163 170
92. E. di Tomaso, M. Snuderl, W.S. Kamoun, D.G. Duda, P.K. Auluck, L. Fazlollahi, O.C. Andronesi, M.P. Frosch, P.Y. Wen, S.R. Plotkin, E.T. Hedley-Whyte, A.G. Sorensen, T.T. Batchelor, R.K. Jain Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape Cancer Res 71 2011 19 28
93. P.P. Zheng, W.C. Hop, T.M. Luider, P.A. Sillevis Smitt, J.M. Kros Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas Ann Neurol 62 2007 40 48 (Pubitemid 47235279)
94. T.T. Batchelor, A.G. Sorensen, E. di Tomaso, W.T. Zhang, D.G. Duda, K.S. Cohen, K.R. Kozak, D.P. Cahill, P.J. Chen, M. Zhu, M. Ancukiewicz, M.M. Mrugala, S. Plotkin, J. Drappatz, D.N. Louis, P. Ivy, D.T. Scadden, T. Benner, J.S. Loeffler, P.Y. Wen, R.K. Jain AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients Cancer Cell 11 2007 83 95 (Pubitemid 46075199)
95. E.R. Gerstner, M.P. Frosch, T.T. Batchelor Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab J Clin Oncol 28 2010 e91 e93
96. T.G. Graeber, C. Osmanian, T. Jacks, D.E. Housman, C.J. Koch, S.W. Lowe, A.J. Giaccia Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature 379 1996 88 91 (Pubitemid 26008141)
97. A. Rapisarda, M. Hollingshead, B. Uranchimeg, C.A. Bonomi, S.D. Borgel, J.P. Carter, B. Gehrs, M. Raffeld, R.J. Kinders, R. Parchment, M.R. Anver, R.H. Shoemaker, G. Melillo Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition Mol Cancer Ther 8 2009 1867 1877
98. M. Selvakumaran, K.S. Yao, M.D. Feldman, P.J. O'Dwyer Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis Biochem Pharmacol 75 2008 627 638
99. M.V. Blagosklonny Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy (review) Int J Oncol 19 2001 257 262
100. O. Keunen, M. Johansson, A. Oudin, M. Sanzey, S.A. Rahim, F. Fack, F. Thorsen, T. Taxt, M. Bartos, R. Jirik, H. Miletic, J. Wang, D. Stieber, L. Stuhr, I. Moen, C.B. Rygh, R. Bjerkvig, S.P. Niclou Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma Proc Natl Acad Sci USA 108 2011 3749 3754